Group One Trading
ATRS

Group One Trading’s Antares Pharma, Inc. ATRS Stock Holding History

Group One Trading’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-85,000
Closed -$349K – 8907
2022
Q1 		$349K Buy
85,000
+47,600
+127% +$173K ﹤0.01% 4226
2021
Q4 		$134K Sell
37,400
-44,500
-54% -$156K ﹤0.01% 5473
2021
Q3 		$298K Sell
81,900
-88,200
-52% -$357K ﹤0.01% 4754
2021
Q2 		$742K Buy
170,100
+7,800
+5% +$31.8K ﹤0.01% 3761
2021
Q1 		$667K Buy
162,300
+127,800
+370% +$554K ﹤0.01% 3708
2020
Q4 		$138K Buy
34,500
+14,100
+69% +$45.6K ﹤0.01% 4336
2020
Q3 		$55K Sell
20,400
-15,200
-43% -$42.1K ﹤0.01% 4594
2020
Q2 		$98K Sell
35,600
-43,800
-55% -$122K ﹤0.01% 3932
2020
Q1 		$187K Sell
79,400
-64,900
-45% -$221K ﹤0.01% 2813
2019
Q4 		$678K Buy
144,300
+105,000
+267% +$430K ﹤0.01% 2194
2019
Q3 		$131K Sell
39,300
-28,000
-42% -$92.2K ﹤0.01% 3378
2019
Q2 		$221K Buy
67,300
+22,900
+52% +$66.3K ﹤0.01% 2781
2019
Q1 		$135K Sell
44,400
-20,100
-31% -$65.1K ﹤0.01% 2975
2018
Q4 		$175K Buy
64,500
+18,000
+39% +$59.3K ﹤0.01% 2788
2018
Q3 		$156K Buy
46,500
+8,100
+21% +$25K ﹤0.01% 3196
2018
Q2 		$99K Buy
38,400
+6,700
+21% +$16.7K ﹤0.01% 3571
2018
Q1 		$70K Buy
31,700
+24,800
+359% +$55.8K ﹤0.01% 3480
2017
Q4 		$14K Buy
6,900
+5,700
+475% +$12.4K ﹤0.01% 4292
2017
Q3 		$4K Sell
1,200
-63,300
-98% -$195K ﹤0.01% 4552
2017
Q2 		$208K Sell
64,500
-14,600
-18% -$41.4K ﹤0.01% 2618
2017
Q1 		$225K Buy
79,100
+30,400
+62% +$73.1K ﹤0.01% 2444
2016
Q4 		$113K Buy
+48,700
New +$92.7K ﹤0.01% 2776
2013
Q3 		– Sell
-93,500
Closed -$389K – 5716
2013
Q2 		$389K Buy
+93,500
New +$361K 0.01% 1555

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's ATRS Position: Q2 2022 in Review

Group One Trading sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 13,427 shares — an estimated $55K sold.

Group One Trading first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $600K in Q4 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Group One Trading reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 13,427 Antares Pharma, Inc. shares in Q2 2022, an estimated $55K.
  • Group One Trading first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
  • Group One Trading's Antares Pharma, Inc. position peaked at $600K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.